Immunome, Inc. (IMNM) Shareholders’ equity 2023–2025
Immunome, Inc. (IMNM) shareholders’ equity at each fiscal year-end, per SEC filings.
$634.3MFY2025 · since FY2023: $119.9M → $634.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $634.3M | +250.1% |
| FY2024 | $181.2M | +51.1% |
| FY2023 | $119.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice